Clinical trial
A Phase 1, Open-Label Pharmacokinetic Study to Investigate Drug Penetration in the Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery
NCT02726438 is registered in ClinicalTrials.gov with Debiopharm International SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Open-Label Pharmacokinetic Study to Investigate Drug Penetration in the Bone After Repeated Oral Administration of Debio 1450 to Patients Undergoing Hip Replacement Surgery
- Lead sponsor
- Debiopharm International SA
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- June 30, 2017
- Enrollment
- 17 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.